Nautilus Biotechnology Inc (NAUT) USD0.0001
1.26%- This stock can be held in a
Stocks and Shares ISA
$0.02
(3.45%)$0.02
(3.45%)Company Information
About this company
Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company is focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. The Company's platform end-to-end solution comprised of the proteome analysis system, consumables, and software. The Company’s products include Proteome Analysis System, and Reagent Kits. Its proteome analysis system is a high-resolution optical imaging system coupled with integrated fluidics and liquid handling sub-systems. The Company’s Reagent Kits are comprised of four main components: sample preparation, flow cell(s), multi-affinity probe reagents, and instrument buffers used to perform multi-cycle analysis runs.
Key people
Key facts
- EPICNAUT
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS63909J1088
- Market cap$93.61m
- Employees155
- Shares in issue126.15m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.